BillionToOne Strengthens Evidence for Prenatal cfDNA Screening
MENLO PARK, Calif., August 18, 2026 BillionToOne, Inc., a molecular diagnostics company developing quantitative genetic testing technologies, has announced...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MENLO PARK, Calif., August 18, 2026 BillionToOne, Inc., a molecular diagnostics company developing quantitative genetic testing technologies, has announced...
BOSTON, August 18, 2026 Curavit Clinical Research, a next-generation clinical research organization (CRO) and Remote Clinical Site, announced the...
SAN DIEGO, Aug. 13, 2026 Daré Bioscience, Inc. reported its second-quarter 2026 financial results and highlighted significant progress in...
DULUTH, Georgia, August 12, 2026 Bridge to Life Ltd., a medical technology company specializing in organ preservation and perfusion...
INDIANAPOLIS, Indiana, August 12, 2026 Eli Lilly and Company has intensified its efforts to combat the illegal sale of...
ST. PAUL, Minnesota, August 11, 2026 Egg Medical, Inc., a medical technology company focused on radiation protection for healthcare...
WALNUT CREEK, California & SHANGHAI, China, August 11, 2026 Dark Horse Consulting Group (DHCG), a life sciences consulting organization...
Denver, Colorado, USA — August 10, 2026 Multidisciplinary Association for Psychedelic Studies (MAPS) responded to reports that Resilient Pharmaceuticals,...
NEW YORK, August 6, 2026 Definium Therapeutics reported its second quarter 2026 financial results and recent business highlights, led...
BOSTON, August 6, 2026 X4 Pharmaceuticals reported second quarter 2026 financial results while highlighting continued progress in the global...
